On January 20, 2026, Arturo Molina, Chief Medical Officer of Protagonist Therapeutics, executed a significant divestment of company shares. The CMO disposed of 9,514 shares in an open-market transaction, generating approximately $784,700 in proceeds at the closing price of $82.48 per share. This act